S100B and schizophrenia: In conclusion, non-convulsive electroconvulsive therapy combined with drug therapy has a significant effect in the therapy of schizophrenia, which can effectively improve psychiatric symptoms and cognitive function of patients, regulate serum BDNF and S100B levels, and is safe.